Early Acute Kidney Injury in Allogeneic Hematopoietic Cell Transplantation: Incidence, Severity, and Associated Factors in a 634‐Recipient Cohort
Open Access
- 21 May 2026
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 117 (4) , 981-994
Abstract
Background: Acute kidney injury (AKI) is a frequent and clinically relevant complication in allogeneic hematopoietic cell transplantation (HCT) recipients, particularly during the early post‐HCT period. Although AKI has been extensively reported in long‐term follow‐up studies, data focusing on the initial hospitalization phase remain limited, despite its potential impact on subsequent clinical outcomes. Objective: To evaluate the incidence, severity, and clinical and transplant‐related determinants of AKI during the first 3 weeks after allogeneic HCT. Methods: We conducted a retrospective cohort study including 634 consecutive recipients undergoing allogeneic HCT between 2002 and 2023. AKI was defined according to KDIGO criteria and assessed from day +1 to day +21. Cumulative incidence was estimated, and associations were evaluated using Cox proportional hazards models. Pre‐AKI exposure to calcineurin inhibitors was analyzed. Results: By day 21, AKI occurred in 346 patients (55%), and 27% of cases reached KDIGO stages 2–3. Median time to AKI was 12 days, with earlier onset among stage 3 events (median 5 days). In multivariable analysis, AST > 40 U/L was independently associated with an increased risk of any‐stage AKI (HR 1.58, 95% CI 1.17–2.12; p = 0.003), whereas albumin > 3.5 g/dL was protective (HR 0.56, 95% CI 0.44–0.71; p < 0.001). Severe AKI was associated with AST > 40 U/L (HR 1.93, 95% CI 1.08–3.44; p = 0.025) and year of transplantation, with higher risk observed in earlier categories (2002–2008: HR 3.68, 95% CI 1.75–7.72; p < 0.001), while higher albumin levels remained inversely associated (HR 0.42, 95% CI 0.26–0.70; p < 0.001). Higher pre‐AKI cyclosporine trough levels (HR 1.11, 95% CI 1.05–1.17; p < 0.001) and a greater proportion of supratherapeutic days (HR 1.06, 95% CI 1.02–1.10; p = 0.005) were also associated with AKI. Conclusion: Early AKI in HCT recipients is strongly associated with baseline clinical vulnerability, hepatic dysfunction, and calcineurin inhibitor exposure. Elevated AST and lower albumin levels identify patients at increased risk, while higher cyclosporine exposure contributes to early renal injury. In contrast, transplant‐related characteristics show limited independent influence. These findings support early risk stratification, careful therapeutic monitoring, and individualized immunosuppression to reduce renal complications during the initial post‐HCT period.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2024/07284‐9)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (26/201.218/2022)
This publication has 35 references indexed in Scilit:
- Prolonged Hospitalization for Hematopoietic Cell Transplantation: Characteristics, Risk Factors and Associations with Patient-Reported and Clinical OutcomesTransplantation and Cellular Therapy, 2025
- Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2023
- Correlates and Outcomes of Early Acute Kidney Injury after Hematopoietic Cell TransplantationThe American Journal of the Medical Sciences, 2021
- Impact of acute kidney injury on overall survival in children and young adults undergoing allogeneic hematopoietic stem cell transplantationPediatric Blood & Cancer, 2021
- Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular TherapyTransplantation and Cellular Therapy, 2020
- Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2016
- International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International ConsortiumTransplantation and Cellular Therapy, 2016
- Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studiesIntensive Care Medicine, 2010
- Critical Care of the Hematopoietic Stem Cell Transplant RecipientCritical Care Clinics, 2010
- The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipientsPediatric Nephrology, 2006